Bioservo Technologies signs additional distribution agreement in Europe
Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has entered an exclusive distribution agreement for selling the all-new Ironhand® with awb Schraubtechnik- und Industriebedarf GmbH
for the Austrian market.
Awb Schraubtechnik- und Industriebedarf GmbH is a well-known partner for industrial supply, tools and protective workwear in Austria. Due to increasing demand from their customers they have added an extensive range of exoskeletons to their portfolio, which now includes the Bioservo Ironhand. Amongst the company’s customers are Austrian subsidiaries of Siemens, BMW and similar companies.
Petter Bäckgren, CEO Bioservo, commented:” We are continuing our expansion and are continuously building the foundation for growth for Ironhand”.
Discussions are ongoing with distributors for additional markets and additional agreements are expected during 2019.
Bioservo’s soft robotic muscle strengthening system Ironhand® comprises a lightweight glove with a portable power pack worn like a backpack. Ironhand® can add up to 80 N to the wearer’s grip within milliseconds. In addition to that, it is equipped with smart data capabilities which makes it possible to digitalize ergonomic risk assessment as well as provide an adaptive performance to the operator over time. At the same time as it supports the wearer, it collects and analyzes data making it possible to evaluate and identify grip intense use cases that run a high ergonomic risk. The wearer is in full control of the system which helps to create a healthy and sustainable work environment.
About Bioservo Technologies
Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company holds a leading global position within soft exoskeleton technology – wearable non-invasive devices – for people in need of extra power to optimise the body’s endurance and performance, or for people with reduced muscle strength.
After many years of research and development, Bioservo Technologies is now focused on a commercialisation of the company’s products and patented technologies. The gloves are well-suited to medical rehabilitation, and to preventive use in a variety of industrial applications. The company has signed strategic cooperation agreements with several multinational companies within e.g. the automotive, aviation as well as the construction and infrastructure industry.
Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public limited company with its headquarters and operations based in Kista, north of Stockholm. FNCA Sweden AB, +46(0)8-528 00399, firstname.lastname@example.org, is the company’s Certified Adviser on Nasdaq First North. To learn more, please visit www.bioservo.com.
For more information, please contact:
Tel.: +46 (0)8 21 17 10
International Business Development
Tel.: +46 (0)8 21 17 10